Skip to main content
OpenTrials

Clinical trial condition

Muscular Disorders, Atrophic

Explore clinical trials studying Muscular Disorders, Atrophic. Study availability and eligibility vary by location and protocol.

622 public trials 123 recruiting studies
Refine in advanced search Browse all conditions

Muscular Disorders, Atrophic trial results

Completed

Aerobic Exercise in Duchenne Muscular Dystrophy

NCT04173234

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Hacettepe University, Faculty of Physical Therapy and Rehabilitation Ankara, Altındağ, Turkey (Türkiye)
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy

NCT02239224

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facioscapulohumeral Muscular Dystrophy (FSHD), Genetic Diseases, Inborn, +7 more
Locations
  • aTyr Pharma Investigative Site Rochester, New York, United States
  • aTyr Pharma Investigative Site Columbus, Ohio, United States
  • aTyr Pharma Investigative Site Marseille, France
  • aTyr Pharma Investigative Site Rome, Italy
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1

NCT03959189

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disorders of Excessive Somnolence, Dyssomnias, +15 more
Locations
  • Stanford Neurosciences Health Center Palo Alto, California, United States
  • Sleep Medicine Specialists of South Florida Miami, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • The Center for Sleep & Wake Disorders Chevy Chase, Maryland, United States
View Trial Details
Completed

Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

NCT03038399

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • University of California Davis Davis, California, United States
  • University of Florida Gainesville, Florida, United States
  • Nemours Children's Hospital Orlando, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States
View Trial Details
Completed

Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients

NCT02530905

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
View Trial Details

Related conditions